Idexx Laboratories 

$570.00
344
+$9.12+1.63% Monday 20:00

統計

當日最高
572.1
當日最低
565.07
52週高點
769.98
52週低點
506.91
成交量
556,180
平均成交量
-
市值
45.39B
本益比
41.33
股息殖利率
-
股息
-

即將到來

財報

4Aug預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
2.4
2.92
3.44
3.96
預期EPS
3.955202
實際EPS
不適用

財務

24.62%利潤率
有盈利
2020
2021
2022
2023
2024
2025
8.61B營收
2.12B淨利

分析師評級

719.17平均目標價
最高預估為 800.00。
來自過去6個月內的 6 則評分。這不是投資建議。
買入
50%
持有
50%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 IDXX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Show more...
執行長
Mr. Jonathan J. Mazelsky
員工
11000
國家
美國
ISIN
US45168D1046

上市

0 Comments

分享你的想法

FAQ

Idexx Laboratories 今天的股價是多少?
IDXX 目前價格為 $570.00 USD,過去 24 小時上漲了 +1.63%。在圖表上更密切關注 Idexx Laboratories 股價表現。
Idexx Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Idexx Laboratories 的股票以代號 IDXX 進行交易。
Idexx Laboratories 的股價在上漲嗎?
IDXX 股票較上週下跌 -1.54%,本月上漲 +7.79%,過去一年 Idexx Laboratories 上漲 +7.8%。
Idexx Laboratories 的市值是多少?
今天 Idexx Laboratories 的市值為 45.39B
Idexx Laboratories 下一次財報日期是什麼時候?
Idexx Laboratories 將於 August 04, 2026 公布下一次財報。
Idexx Laboratories 上一季度的財報如何?
IDXX 上一季度的財報為每股 3.47 USD,預估為 3.41 USD,帶來 +1.76% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Idexx Laboratories 去年的營收是多少?
Idexx Laboratories 去年的營收為 8.61BUSD。
Idexx Laboratories 去年的淨利是多少?
IDXX 去年的淨收益為 2.12BUSD。
Idexx Laboratories 有多少名員工?
截至 June 16, 2026,公司共有 11,000 名員工。
Idexx Laboratories 位於哪個產業?
Idexx Laboratories從事於Health & Wellness產業。
Idexx Laboratories 何時完成拆股?
Idexx Laboratories 上次拆股發生於 June 16, 2015,比例為 2:1。
Idexx Laboratories 的總部在哪裡?
Idexx Laboratories 的總部位於 美國 的 Westbrook。